← Every company

Kura Oncology Inc Insider Trading

Every director, officer and 10% holder of Kura Oncology Inc has to report each trade in its stock within two business days of making it. This is those filings.

KURA on carbonthat →
Insiders filing
8
17 reported lines
Open-market buys
2
$2.4M
Open-market sales
12
$1.7M
Net
$643K
bought more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Kathleen FordChief Operating Officer2026-09-293.7K shat $10.75
Sale10b5-1 plan
$39.4K
Mollie LeoniChief Medical Officer2026-09-2928.8K shat $10.75
Sale
$309.6K
Brian T. PowlChief Commercial Officer2026-09-2915.4K shat $10.75
Sale
$165.9K
Teresa Brophy BairChief Legal Officer2026-09-288.4K shat $10.50
Sale10b5-1 plan
$88.6K
Kathleen FordChief Operating Officer2026-09-286.9K shat $10.50
Sale10b5-1 plan
$72.5K
Mollie LeoniChief Medical Officer2026-09-2812.4K shat $10.50
Sale
$130.7K
Thomas James DoyleSVP, Finance & Accounting2026-09-284.6K shat $10.50
Sale
$48.4K
Brian T. PowlChief Commercial Officer2026-09-289K shat $10.50
Sale
$94.7K
Brian T. PowlChief Commercial Officer2026-09-288K shat $10.56
Sale
$84.5K
Francis BurrowsChief Scientific Officer2026-09-2420.7K shat $10.83
Sale
$224.5K
Troy Edward WilsonPresident and CEO2026-08-24100K shat $12.39
Purchase
$1.2M
Brian T. PowlChief Commercial Officer2026-08-214.3K shat $11.89
Sale10b5-1 plan
$51.7K
Teresa Brophy BairChief Legal Officer2026-08-1931.5K shat $12.63
Sale10b5-1 plan
$397.7K
Troy Edward WilsonPresident and CEO2026-08-17100K shat $11.12
Purchase
$1.1M

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on KURA

Follow Kura Oncology Inc (KURA) by email

New trades in Kura Oncology Inc (KURA) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets